Christian R. Dolder, Pharm.D., BCPS
Reportable Conflicts of Interests: None
Disclosure of Financial Conflicts of Interest: None
Education:
Doctor of Pharmacy
University of the Pacific
School of Pharmacy
Valedictorian
Pre-pharmacy
University of the Pacific
Stockton, CA
Post Graduate or Residency Training:
Geriatrics Clinical Pharmacy Practice Resident
VA San Diego Healthcare System
La Jolla, CA
Fellowship and Board Certifications:
Board Certified Pharmacotherapy Specialist
Current Position or Practice Site:
Associate Professor
Wingate University School of Pharmacy
Past Positions and/or Appointments:
Assistant Professor
Department of Psychiatry
University of California, San Diego
Clinical Pharmacist (per diem)
VA San Diego Healthcare System
La Jolla, CA
Professional Memberships:
American Association of Colleges of Pharmacy
North Carolina Association of Pharmacists
American Association for Geriatric Psychiatry
American College of Clinical Pharmacy
College of Psychiatric and Neurologic Pharmacists
American Society of Health System Pharmacists
Phi Delta Chi Professional Pharmacy Fraternity
Publications:
Dolder C, Nelson M, McKinsey J. Memantine dosing in patients with dementia. Am J Geriatr Psychiatry (in press)
Dolder CR, Nelson M. Hypnosedative-induced complex behaviours: Incidence, mechanisms, and management. CNS Drugs 2008;22:1021-36.
Dolder CR, Nelson M, Snider M. Agomelatine treatment of major depressive disorder. Ann Pharmacother 2008;42:1822-31.
Dolder C, Nelson M, Deyo Z. Paliperidone for schizophrenia. Am J Health-System Pharm 2008;65:403-13.
Dolder C, Szymanski B, Wooton T, McKinsey J. Pharmacist interventions in an inpatient geriatric psychiatry unit. Am J Health-System Pharm 2008;65:1795-6.
Howitt JR, Grace JW, Schaefer MG, Dolder C, Cannella C, Schaefer RS. Clostridium difficile-positive stools: a retrospective identification of risk factors. Am J Infect Control 2008;36:488-91.
Dolder C, Nakagawa S, Sakamaki A, Supernaw R. Changes in Japanese pharmacy education and practice. Am J Health-System Pharm 2008;65:201-2.
Dolder CR, Veverka A, Nuzum DS, McKinsey J. Cardiovascular medication prescribing in older adults with psychiatric disorders. Consultant Pharmacist 2007;22:660-8.
Gilmer TP, Dolder CR, Folsom DP, Mastin W, Jeste DV. Antipsychotic polypharmacy trends among Medi-Cal beneficiaries with schizophrenia in San Diego County, 1999-2004. Psychiatr Serv 2007;58:1007-10.
Dolder C, Nelson M, McKinsey J. The use of non-benzodiazepine hypnotics in the elderly: Are all agents the same? CNS Drugs 2007:389-405.
Nelson M, Dolder CR. A review of lapatinib ditosylate in the treatment of refractory or advanced breast cancer. Therapeutics and Clinical Risk Management 2007;3:665-73.
Ascher-Svanum H, Zhu B, Faries D, Lacro JP, Dolder CR. A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia. J Clin Psychiatry 2006;67:1114-23.
Dolder CR. Dutasteride: a dual 5-alpha reductase inhibitor for the treatment of symptomatic benign prostatic hyperplasia. Ann Pharmacother 2006;40:658-65.
Nelson MH, Dolder CR. Lapatinib: a novel tyrosine kinase inhibitor with activity in solid tumors. Ann Pharmacother 2006;40:261-9.
Jeste DV, Dolder CR, Nayak GV, Salzman C. Atypical antipsychotics in dementia and late-life schizophrenia. Harv Rev Psychiatry 2005;13:340-51.
Dolder CR, Supernaw RB. Use of e-mail communication to develop relationships between pharmacy students and patients. Am J Pharm Ed 2005;69:184-9.
Dolder CR, Furtek K, Lacro JP, Jeste DV. Antihypertensive medication adherence and blood pressure control in patients with psychotic disorders compared to persons without psychiatric illness. Psychosomatics 2005;46:135-41.
Dolder CR, Lacro JP, Warren KA, Golshan S, Perkins DO, Jeste DV. Brief evaluation of medication influences and beliefs: Development and testing of a brief scale for medication adherence. J Clin Psychopharm 2004;24:404-9.
Gilmer TP, Dolder CR, Lacro JP, Folsom DP, Lindamer L, Garcia P, Jeste DV. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am J Psychiatry 2004;161:692-99.
Jeste DV, Dolder CR. Treatment of non-schizophrenic disorders: Focus on atypical antipsychotics. Journal of Psychiatric Research 2004;38:73-103.
Dolder CR, Patterson TL, Jeste DV. HIV, psychosis and aging: Past, present and future. AIDS 2004;18(Suppl 1):S35-S42.
Dolder C. Cautionary notes on the use of monoamine oxidase inhibitors. American Journal of Pain Management 2003;13:144-5.
Dolder CR, Lacro JP, Jeste DV. Adherence to antipsychotic and nonpsychiatric medications in older patients with psychotic disorders. Psychosom Med 2003;65:156-62.
Dolder CR, Lacro JP, Leckband S, Jeste DV. Interventions to improve antipsychotic medication adherence: Review of recent literature. J Clin Psychopharm 2003;23:389-99.
Dolder C, Lacro J, Dolder N, Gregory P. Pharmacists' use of and attitudes and beliefs about alternative medications. Am J Health-System Pharm 2003;60:1352-7.
Dolder CR, Jeste DV. Incidence of tardive dyskinesia with typical versus atypical antipsychotics in very high risk patients. Biol Psychiatr 2003;53:1142-5.
Jeste SD, Patterson TL, Palmer BW, Dolder CR, Goldman S, Jeste DV. Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia. Schiz Res 2003;63:49-58.
Dolder CR, Lacro JP, Dunn LB Jeste DV. Medication adherence: Is there a difference
between typical and atypical antipsychotics? Am J Psychiatry 2002;159:103-8.
Kindermann SS, Dolder CR, Bailey A, Katz I, Jeste DV. Treatment of psychosis and
agitation in elderly patients with dementia: Four decades of experience. Drugs Aging
2002;19:257-76.
Dolder C, Lacro J, Dolder N, Gregory P. Complementary and alternative medication use in a veteran population. Consultant Pharmacist 2002;17:653-62.
Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature. J Clin Psychiatry 2002;63:892-909.
Invited Contributions:
Lacro JP, Dolder CR. Antipsychotics. In: Sadock BJ, Sadock VA, Ruiz P, Eds., Kaplan and Sadock’s Comprehensive Textbook of Psychiatry (9th Ed.), Philadelphia: Lippincott, Williams & Wilkins (in press).
Dolder CR, Lacro JP, Jeste DV. Antipsychotics in late-life depression. In Roose SP & Sackheim HA, Eds., Late-Life Depression, New York: Oxford University Press (in press).
Dolder CR. Psychosis. In: 2009 Omnicare Geriatric Pharmaceutical Care Guidelines.
Dolder CR. Behavioral Disturbances in Dementia. In: 2009 Omnicare Geriatric Pharmaceutical Care Guidelines.
Dolder C. Review: paliperidone reduces symptoms of schizophrenia and schizophrenia-like illness. Evidenced-Based Mental Health 2008;11:114.
Dolder CR. Psychosis. In: 2008 Omnicare Geriatric Pharmaceutical Care Guidelines.
Dolder CR, Depp CA, Jeste DV. Biologic treatments of bipolar disorder in later life. In: Sajatovic M and Blow FC, Eds., Bipolar Disorder in Later Life, Baltimore: The Johns Hopkins University Press 2007.
Dolder CR. Psychosis. In: 2007 Omnicare Geriatric Pharmaceutical Care Guidelines.
Jeste DV, Dolder CR, Wetherell JL. Schizophrenia and Paranoid Disorders. In: Blazer DG, Steffens DC, Busse EW, Eds., Essentials of Geriatric Psychiatry, Washington DC: American Psychiatric Publishing 2007.
Dolder CR. Depression. In: Shapiro K, Ed, Natural Products: A case-based approach for healthcare professionals, Washington DC: APhA 2006.
Dolder C, Smith L. Urinary incontinence: Anticholinergic agents, genitourinary smooth muscle relaxants. In: 2006 Omnicare Geriatric Pharmaceutical Care Guidelines.
Dolder C, Luna B. Psychopharmacology: a pharmacodynamic approach. In: Jeste DV and Friedman JH (eds). Current Clinical Neurology: Psychiatry for Neurologists, Totowa NJ: Human Press 2005.
Dolder CR, Jeste DV. Schizophrenia and delusional disorders. In: Sadock BJ & Sadock VA, Eds., Kaplan & Sadock’s Comprehensive Textbook of Psychiatry (8th ed), Philadelphia: Lippincott Willams & Wilkins 2004.
Jeste DV, Wetherell JL, Dolder CR. Schizophrenia and Paranoid Disorders. In: Blazer DG, Steffens DC, Busse EW (Eds.), The American Psychiatric Publishing Textbook of Geriatric Psychiatry (3rd edition). Washington DC 2004.
Dolder CR. Diagnosis and treatment of psychiatric and behavioral disturbances in Alzheimer disease: A review of recent literature. Current Psychosis and Therapeutic Reports 2004;2:13-20.
Dolder CR. Antipsychotics Update. Drug Facts and Comparisons NEWS: Keeping Up. July 2004;51-53.
Jeste DV, Naimark D, Dolder CR. Medication-induced movement disorders. In: Tasman A, Kay J, Lieberman JA (Eds.), Psychiatry (2nd edition). London: Wiley and Sons 2003.
Twamley, EW, Dolder, CR, Corey-Bloom, J, & Jeste, DV. Neuropsychiatric aspects of schizophrenia. In Fogel, BS, Schiffer RB, & Rao, SM, eds., Neuropsychiatry: A Comprehensive Textbook (2nd ed), Philadelphia: Lippincott Williams & Wilkins 2003.
Co-authored a CE article published in Insights (California Pharmacists Association Newsletter 1998) Volume 10, No. 3, entitled "Improving Patient Compliance and Care Through the Pharmacist-Patient Relationship."
Presentations:
Provided a CE presentation entitled, “Medical Literature Update” at the 2008 North Carolina Association of Pharmacists Annual Convention. Oct. 2008
Presented findings at the American Association of Colleges of Pharmacy Annual Meeting on, “Student perceptions of ability and preparedness for a problem-based oncology pharmacotherapy course.” (poster) July 2008
Presented findings at the American Association of Colleges of Pharmacy Annual Meeting on, “An Individualized Learning Program for a Psychiatric Pharmacotherapy Course.” (poster) July 2007
Provided continuing education presentation entitled, “2007: The State of Antipsychotics” at the North Carolina Association of Pharmacists 2007 Acute Care Forum. April 2007
Presented findings at the American Association of Colleges of Pharmacy Annual Meeting on, “Active Learning in a Geriatrics Pharmacotherapy Course.” (poster) July 2006
Presented findings at the American Association of Colleges of Pharmacy Annual Meeting on, “Development and Implementation of a Novel Problem-Based Learning Case Studies Course.” (poster) July 2005
Featured symposium presenter at the American Psychiatric Nurses Association Annual Meeting. Lectured on “Medication, Schizophrenia, and Functioning.” Sep. 2004
Presented findings at the American Association for Geriatric Psychiatry Annual Meeting on, “Antihypertensive medication adherence and blood pressure control in older adults with psychotic disorders compared to persons without psychiatric illness.” (poster) Mar. 2004
Presented findings at the American Academy of Neurology Annual Meeting on, “Incidence of tardive dyskinesia with typical versus atypical antipsychotics in very high risk patients.” (poster) Mar. 2003
Presented findings at the American Association for Geriatric Psychiatry Annual Meeting on, “Development and evaluation of a brief scale to assess medication adherence.” (poster) Feb. 2003
Presented findings at the American Society of Health System Pharmacist Midyear Clinical Meeting on, “Survey of pharmacists to examine the use of, attitudes, and beliefs toward alternative medications.” (poster) Dec. 2002
Gave lecture to UCSD pharmacy students entitled, “Complementary and Alternative Medications: Review and Clinical Update.” Nov. 2002
Gave lecture entitled, “Psychiatric Medications and the Older Adult” as part of San Diego County Adult Mental Health Services 2002 Older Adult Mental Health Conference. Oct. 2002
Gave lecture entitled, “Herbal products: Use in Geriatrics and Psychiatry” as part of geriatric psychiatry seminar series. June 2002
Presented findings at the College of Psychiatric and Neurologic Pharmacists Annual Meeting on, “Identifying antipsychotic nonadherence: The use of a medication influence and belief survey.” April 2002
Presented findings at the American Association for Geriatric Psychiatry Annual Meeting on, “Adherence to antipsychotic and nonpsychiatric medications in older patients with psychotic disorders.” (poster) Feb. 2002
Presented findings at the American Society of Health System Pharmacists Midyear Clinical Meeting on, “Utilizing pharmacy refill records to assess risk for psychiatric hospitalization and clinic visits.” (poster) Dec. 2001
Presented preliminary findings at the College of Psychiatric and Neurologic Pharmacists Annual Meeting on, “Medication Adherence Therapy in Older Patients with Psychosis.” (poster) Mar. 2001
Presented findings at the American Association For Geriatric Psychiatry Annual Meeting on, “Medication adherence in older patients on atypical versus typical antipsychotics.” (poster) Feb. 2001
Presented findings at the Western States Conference involving residency research project, “Clinical effects of glyburide dose-reduction in type 2 diabetics.” May 2000
(Last Updated: 05/29/09)
